AUSTIN, Texas; June 22, 2023 – Elligo Health Research®, the largest healthcare-enabling research organization, launched an updated version of its IntElligo® Study Marketplace, a technology-enabled solution that supports research sites in building a strong study pipeline. This user-friendly platform enables sites to quickly and easily browse a list of available studies, review study documents, apply for those of interest, track progress, and collaborate among team members and Elligo throughout the sales cycle. The Study Marketplace includes a list of curated studies for sites based on interests, capabilities, and patient population.
“Elligo has been helping sites manage their study pipelines for years, and we know how challenging it is to identify new study opportunities and manage the sales cycle,” said Elligo Vice President, Network Expansion Riley Kammer. “There are countless emails, feasibility questionnaires, long wait times for studies, and more. Study Marketplace enhances the process of finding and matching studies for sites. Not only is the platform continuously updated with a list of curated studies that eliminates the need to search, but it also notifies users about any actions needed for study applications, tracks site selection progress, and streamlines collaboration.”
The platform was first introduced as a beta option and will be accessible to everyone in Elligo’s Research Network of sites. Early feedback was positive, as demonstrated by the successful adoption of 98% of sites. Elligo continues to invest in and improve the Study Marketplace platform to provide more sites with better pipeline management.
“Physician PIs and Coordinators have a lot of activities to complete in order to provide innovative clinical trials to patients,” said Elligo’s Chief Medical Officer, Faith Holmes, M.D. “Giving sites a single tool to easily organize studies of interest without endless emails and phone calls allows for acceleration, transparency, and most importantly, time savings. We can spend more time on trial execution and patient care.”
About Elligo Health Research®
Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites. Our PatientSelect® model engages our network of networks to optimize the intersection of healthcare and research and bring more patients clinical research as a care option. Our SiteSelect model and Research Partner Services enable sites to seamlessly participate in trials, further advancing the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.